Literature DB >> 8819111

Inheritance of randomness.

B A Afzelius1.   

Abstract

The mouse mutant iv is characterized by "a random determination of a developmental process' in that 50 rather than 100% of the homozygotes have situs inversus. The same explanation is given to the inheritance of situs inversus in the human immotile-cilia syndrome. There are probably two alleles of the responsible gene, one for control of the proper asymmetry and one without control and hence resulting in equal numbers of situs solitus and situs inversus in the homozygote. Left-handedness may be similarly inherited; furthermore, because of its high prevalence (around 10-12%) it has been assumed that there is an advantage of carrying both alleles ("balanced polymorphism'). With these two assumptions, a prevalence of left-handedness of 12.5% is expected, a 50% chance of left-handedness in matings between two left-handed persons, and equal numbers of discordant and left-handed concordant monozygotic twins. These values are close to those actually found. As the values for (female) homosexuality are similar to those of left-handedness a similar inheritance is proposed.

Entities:  

Mesh:

Year:  1996        PMID: 8819111     DOI: 10.1016/s0306-9877(96)90037-7

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  A locus for primary ciliary dyskinesia maps to chromosome 19q.

Authors:  M Meeks; A Walne; S Spiden; H Simpson; H Mussaffi-Georgy; H D Hamam; E L Fehaid; M Cheehab; M Al-Dabbagh; S Polak-Charcon; H Blau; A O'Rawe; H M Mitchison; R M Gardiner; E Chung
Journal:  J Med Genet       Date:  2000-04       Impact factor: 6.318

Review 2.  Perioperative implications and management of dextrocardia.

Authors:  Yury Rapoport; Charles J Fox; Parth Khade; Mary E Fox; Richard D Urman; Alan David Kaye
Journal:  J Anesth       Date:  2015-05-10       Impact factor: 2.078

Review 3.  Cilia-related diseases.

Authors:  B A Afzelius
Journal:  J Pathol       Date:  2004-11       Impact factor: 7.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.